论文信息 - Randomized phase III ANGEL study of rivoceranib (apatinib) + best supportive care (BSC) vs placebo + BSC in patients with advanced/metastatic gastric cancer who failed ≥2 prior chemotherapy regimens - 字舞流文

Randomized phase III ANGEL study of rivoceranib (apatinib) + best supportive care (BSC) vs placebo + BSC in patients with advanced/metastatic gastric cancer who failed ≥2 prior chemotherapy regimens

Yoon-Koo Kang | L. Wyrwicz | Y. Chao | S. Cascinu | M. Ryu | M. Schenker | I. Chau | A. Takashima | N. Sankar | N. Boku | K. Lee | S. Oh | M. Bartolomeo | H. Yoon | V. Vladimirov | W. Kang | L. Evesque | A. McGinn | A. Kryzhanivska | Jong-Guk Kim | A. Mcginn